Stocks and Investing
Stocks and Investing
Tue, July 5, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, July 4, 2022
[ 12:00 AM ] - United States, WOPRAI
Sun, July 3, 2022
Fri, July 1, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kevin Fischbeck Maintained (UHS) at Sell with Decreased Target to $106 on, Jul 1st, 2022
Kevin Fischbeck of B of A Securities, Maintained "Universal Health Services, Inc." (UHS) at Sell with Decreased Target from $123 to $106 on, Jul 1st, 2022.
Kevin has made no other calls on UHS in the last 4 months.
There are 9 other peers that have a rating on UHS. Out of the 9 peers that are also analyzing UHS, 4 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $108 on, Thursday, June 30th, 2022
- Joseph France of "Loop Capital" Initiated at Hold and Held Target at $115 on, Friday, June 17th, 2022
- Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $135 on, Wednesday, April 27th, 2022
- Ben Hendrix of "RBC Capital" Maintained at Hold with Decreased Target to $130 on, Wednesday, April 27th, 2022
These are the ratings of the 5 analyists that currently disagree with Kevin
- Jamie Perse of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $125 on, Tuesday, May 3rd, 2022
- Stephen Baxter of "Wells Fargo" Maintained at Sell with Decreased Target to $118 on, Thursday, April 28th, 2022
- Steven Valiquette of "Barclays" Maintained at Sell with Decreased Target to $133 on, Wednesday, April 27th, 2022
- Andrew Mok of "UBS" Maintained at Strong Sell with Decreased Target to $129 on, Tuesday, April 26th, 2022
- Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $167 on, Tuesday, March 1st, 2022
Contributing Sources